Alok Singh Selected Research

Alok Singh Research Topics

Disease

4	COVID-19 10/2022 - 07/2020
4	Migraine Disorders (Migraine) 04/2022 - 04/2020
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2023 - 01/2022
3	Neoplasms (Cancer) 10/2022 - 01/2018
2	Schizophrenia (Dementia Praecox) 01/2024 - 10/2022
1	Ischemic Stroke 04/2024
1	Nausea 02/2024
1	Vomiting 02/2024
1	Weight Gain 01/2024
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2024
1	Nervous System Diseases (Neurological Disorders) 11/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2023
1	Stroke (Strokes) 11/2023
1	Rett Syndrome (Rett's Disorder) 11/2023
1	Breast Neoplasms (Breast Cancer) 10/2023
1	Guillain-Barre Syndrome 07/2023
1	Polyuria 07/2023
1	Carcinogenesis 03/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Epilepsy (Aura) 05/2022
1	Headache (Headaches) 04/2022
1	Seizures (Absence Seizure) 01/2022
1	Sleepiness 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2021
1	Pain (Aches) 03/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Dentin Sensitivity 07/2020
1	Hallucinations (Hallucination) 01/2019
1	Sensorineural Hearing Loss 01/2019
1	Type 2 Diabetes Mellitus (MODY) 06/2018
1	Squamous Cell Carcinoma of Head and Neck 04/2018
1	Fibrosis (Cirrhosis) 04/2018
1	Opportunistic Infections (Opportunistic Infection) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypertension (High Blood Pressure) 12/2013
1	Cushing Syndrome 12/2013
1	Heart Failure 12/2013
1	Thrombosis (Thrombus) 02/2007

Drug/Important Bio-Agent (IBA)

3	ViloxazineIBA 10/2023 - 01/2022
2	Olanzapine (Zyprexa)FDA Link 02/2024 - 01/2024
2	Calcitonin Gene-Related PeptideIBA 04/2022 - 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2024
1	Tenecteplase FDA Link 04/2024
1	3-carboxamido-4-hydroxynaltrexoneIBA 01/2024
1	lybalviIBA 01/2024
1	Insulin-Like PeptidesIBA 11/2023
1	trofinetideIBA 11/2023
1	Methyl-CpG-Binding Protein 2IBA 11/2023
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 10/2023
1	Mannitol (Osmitrol)FDA LinkGeneric 07/2023
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 07/2023
1	DiureticsIBA 07/2023
1	MicroRNAs (MicroRNA)IBA 03/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 10/2022
1	AntibodiesIBA 10/2022
1	Cholinergic AgonistsIBA 10/2022
1	xanomelineIBA 10/2022
1	Rituximab (Mabthera)FDA Link 10/2022
1	Drug CombinationsIBA 10/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 05/2022
1	atogepantIBA 04/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2022
1	STI-2020IBA 01/2022
1	CenobamateIBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2021
1	Budesonide (Pulmicort)FDA LinkGeneric 08/2021
1	ubrogepantIBA 03/2021
1	rimegepant sulfateIBA 03/2021
1	lasmiditanIBA 03/2021
1	SF 1126IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	opicaponeIBA 01/2021
1	istradefyllineIBA 01/2021
1	SF2523IBA 01/2021
1	Sodium Fluoride (Ossin)FDA Link 07/2020
1	Ivermectin (Mectizan)FDA Link 07/2020
1	FluoridesIBA 07/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019
1	Donepezil (Aricept)FDA LinkGeneric 01/2019
1	Blood Glucose (Blood Sugar)IBA 06/2018
1	CholesterolIBA 06/2018
1	HDL CholesterolIBA 06/2018
1	Triglycerides (Triacylglycerol)IBA 06/2018
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	ArsenicIBA 01/2017
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 12/2013
1	AldosteroneIBA 12/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 02/2024 - 10/2023
1	Length of Stay 07/2023
1	Semiconductor Lasers 07/2020
1	Cochlear Implantation 01/2019
1	Stents 02/2007